| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $4.1M | +31.3% |
| Cost of Revenue | $893K | +3.1% |
| Gross Profit | $3.2M | +42.0% |
| R&D Expense | $8K | -95.8% |
| SG&A Expense | $3.0M | +45.9% |
| Pre-tax Income | -$154K | +43.3% |
| Income Tax | $0 | — |
| Net Income | -$154K | +43.3% |
| EPS (Basic) | $0.00 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | +32.3% |
| Accounts Receivable | $208K | -9.7% |
| Inventory | $104K | +149.3% |
| Current Assets | $1.5M | +27.1% |
| Total Assets | $1.6M | +23.6% |
| Total Liabilities | $2.0M | +30.7% |
| Stockholders' Equity | -$357K | -76.2% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $284K | -31.5% |
| Investing Cash Flow | -$10K | +88.1% |
| — |
| EPS (Diluted) | $0.00 | — |